Expert opinion in biological therapy: update on developments in lung gene transfer

Bibliography

• American Society of Cell and Gene Therapy. 2000
   Google Scholar
• Breeze RG, Wheeldon EB. The cells of the pulmonary airways. Am Rev Respir Dis 1977;116:705-77
   PubMed Web of Science ®Google Scholar
• Griesenbach U, Alton EW. Progress in gene and cell therapy for cystic fibrosis lung disease. Curr Pharm Des 2012;18:642-62
   PubMed Web of Science ®Google Scholar
• Pickles RJ, McCarty D, Matsui H, Limited entry of adenovirus vectors into well-differentiated airway epithelium is responsible for inefficient gene transfer. J Virol 1998;72:6014-23
   PubMed Web of Science ®Google Scholar
• Walters RW, Grunst T, Bergelson JM, Basolateral localization of fiber receptors limits adenovirus infection from the apical surface of airway epithelia. J Biol Chem 1999;274:10219-26
   PubMed Web of Science ®Google Scholar
• Weiss DJ, Beckett T, Bonneau L, Transient increase in lung epithelial tight junction permeability: an additional mechanism for enhancement of lung transgene expression by perfluorochemical liquids. Mol Ther 2003;8:927-35
   PubMed Web of Science ®Google Scholar
• Koehler DR, Frndova H, Leung K, Aerosol delivery of an enhanced helper-dependent adenovirus formulation to rabbit lung using an intratracheal catheter. J Gene Med 2005;7:1409-20
   PubMed Web of Science ®Google Scholar
• Flotte TR, Ng P, Dylla DE, Viral vector-mediated and cell-based therapies for treatment of cystic fibrosis. Mol Ther 2007;15:229-41
   PubMed Web of Science ®Google Scholar
• Duan D, Sharma P, Yang J, Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue. J Virol 1998;72:8568-77
   PubMed Web of Science ®Google Scholar
• Flotte TR. Recent developments in recombinant AAV-mediated gene therapy for lung diseases. Curr Gene Ther 2005;5:361-6
   PubMed Web of Science ®Google Scholar
• McCarty DM, Young SM Jr, Samulski RJ. Integration of adeno-associated virus (AAV) and recombinant AAV vectors. Annu Rev Genet 2004;38:819-45
   PubMed Web of Science ®Google Scholar
• Gao G, Vandenberghe LH, Wilson JM. New recombinant serotypes of AAV vectors. Curr Gene Ther 2005;5:285-97
   PubMed Web of Science ®Google Scholar
• Limberis MP, Vandenberghe LH, Zhang L, Transduction efficiencies of novel AAV vectors in mouse airway epithelium in vivo and human ciliated airway epithelium in vitro. Mol Ther 2009;17:294-301
   PubMed Web of Science ®Google Scholar
• Flotte TR, Fischer AC, Goetzmann J, Dual reporter comparative indexing of rAAV pseudotyped vectors in chimpanzee airway. Mol Ther 2010;18:594-600
   PubMed Web of Science ®Google Scholar
• Bell CL, Vandenberghe LH, Bell P, The AAV9 receptor and its modification to improve in vivo lung gene transfer in mice. J Clin Invest 2011;121:2427-35
   PubMed Web of Science ®Google Scholar
• Maheshri N, Koerber JT, Kaspar BK, Directed evolution of adeno-associated virus yields enhanced gene delivery vectors. Nat Biotechnol 2006;24:198-204
   PubMed Web of Science ®Google Scholar
• Excoffon KJ, Koerber JT, Dickey DD, Directed evolution of adeno-associated virus to an infectious respiratory virus. Proc Natl Acad Sci USA 2009;106:3865-70
   PubMed Web of Science ®Google Scholar
• Li W, Zhang L, Johnson JS, Generation of novel AAV variants by directed evolution for improved CFTR delivery to human ciliated airway epithelium. Mol Ther 2009;17:2067-77
   PubMed Web of Science ®Google Scholar
• Duan D, Yue Y, Engelhardt JF. Expanding AAV packaging capacity with trans-splicing or overlapping vectors: a quantitative comparison. Mol Ther 2001;4:383-91
   PubMed Web of Science ®Google Scholar
• Halbert CL, Allen JM, Miller AD. Efficient mouse airway transduction following recombination between AAV vectors carrying parts of a larger gene. Nat Biotechnol 2002;20:697-701
   PubMed Web of Science ®Google Scholar
• Song Y, Lou HH, Boyer JL, Functional cystic fibrosis transmembrane conductance regulator expression in cystic fibrosis airway epithelial cells by AAV6.2-mediated segmental trans-splicing. Hum Gene Ther 2009;20:267-81
   PubMed Web of Science ®Google Scholar
• Ferrari S, Griesenbach U, Shiraki-Iida T, A defective nontransmissible recombinant Sendai virus mediates efficient gene transfer to airway epithelium in vivo. Gene Ther 2004;11:1659-64
   PubMed Web of Science ®Google Scholar
• Zhang L, Bukreyev A, Thompson CI, Infection of ciliated cells by human parainfluenza virus type 3 in an in vitro model of human airway epithelium. J Virol 2005;79:1113-24
   PubMed Web of Science ®Google Scholar
• Okada Y. Sendai virus-induced cell fusion. Methods Enzymol 1993;221:18-41
   PubMed Web of Science ®Google Scholar
• Li HO, Zhu YF, Asakawa M, A cytoplasmic RNA vector derived from nontransmissible Sendai virus with efficient gene transfer and expression. J Virol 2000;74:6564-9
   PubMed Web of Science ®Google Scholar
• Inoue M, Tokusumi Y, Ban H, Nontransmissible virus-like particle formation by F-deficient sendai virus is temperature sensitive and reduced by mutations in M and HN proteins. J Virol 2003;77:3238-46
   PubMed Web of Science ®Google Scholar
• Kobayashi M, Iida A, Ueda Y, Pseudotyped lentivirus vectors derived from simian immunodeficiency virus SIVagm with envelope glycoproteins from paramyxovirus. J Virol 2003;77:2607-14
   PubMed Web of Science ®Google Scholar
• Mitomo K, Griesenbach U, Inoue M, Toward gene therapy for cystic fibrosis using a lentivirus pseudotyped with sendai virus envelopes. Mol Ther 2010;18:1173-82
   PubMed Web of Science ®Google Scholar
• Sinn PL, Arias AC, Brogden KA, Lentivirus vector can be readministered to nasal epithelia without blocking immune responses. J Virol 2008;82:10684-92
   PubMed Web of Science ®Google Scholar
• McKay T, Patel M, Pickles RJ, Influenza M2 envelope protein augments avian influenza hemagglutinin pseudotyping of lentiviral vectors. Gene Ther 2006;13:715-24
   PubMed Web of Science ®Google Scholar
• Sinn PL, Sauter SL, McCray PB Jr. Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors–design, biosafety, and production. Gene Ther 2005;12:1089-98
   PubMed Web of Science ®Google Scholar
• Wilson AA, Murphy GJ, Hamakawa H, Amelioration of emphysema in mice through lentiviral transduction of long-lived pulmonary alveolar macrophages. J Clin Invest 2010;120:379-89
   PubMed Web of Science ®Google Scholar
• Limberis M, Anson DS, Fuller M, Recovery of airway cystic fibrosis transmembrane conductance regulator function in mice with cystic fibrosis after single-dose lentivirus-mediated gene transfer. Hum Gene Ther 2002;13:1961-70
   PubMed Web of Science ®Google Scholar
• Cmielewski P, Anson DS, Parsons DW. Lysophosphatidylcholine as an adjuvant for lentiviral vector mediated gene transfer to airway epithelium: effect of acyl chain length. Respir Res 2010;11:84
   PubMed Web of Science ®Google Scholar
• Medina MF, Kobinger GP, Rux J, Lentiviral vectors pseudotyped with minimal filovirus envelopes increased gene transfer in murine lung. Mol Ther 2003;8:777-89
   PubMed Web of Science ®Google Scholar
• Griesenbach U, Inoue M, Hasegawa M, Viral vectors for cystic fibrosis gene therapy - what does the future hold? Virus Adaptat Treat 2010;2010:159-71
   Google Scholar
• Griesenbach U, McLachlan G, Owaki T, Validation of recombinant sendai virus in a non-natural host model. Gene Ther 2010;18:182-8
   PubMed Web of Science ®Google Scholar
• Booth C, Gaspar HB, Thrasher AJ. Gene therapy for primary immunodeficiency. Curr Opin Pediatr 2011;23:659-66
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Thrasher AJ. Progress and prospects: advancements in retroviral vector design, generation, and application. Hum Gene Ther 2011;22:1171-4
   PubMed Web of Science ®Google Scholar
• Pichon C, Billiet L, Midoux P. Chemical vectors for gene delivery: uptake and intracellular trafficking. Curr Opin Biotechnol 2010;21:640-5
   PubMed Web of Science ®Google Scholar
• Hyde SC, Southern KW, Gileadi U, Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis. Gene Ther 2000;7:1156-65
   PubMed Web of Science ®Google Scholar
• Ziady AG, Kelley TJ, Milliken E, Functional evidence of CFTR gene transfer in nasal epithelium of cystic fibrosis mice in vivo following luminal application of DNA complexes targeted to the serpin-enzyme complex receptor. Mol Ther 2002;5:413-19
   PubMed Web of Science ®Google Scholar
• Tagalakis AD, McAnulty RJ, Devaney J, A receptor-targeted nanocomplex vector system optimized for respiratory gene transfer. Mol Ther 2008;16:907-15
   PubMed Web of Science ®Google Scholar
• Davies LA, McLachlan G, Sumner-Jones SG, Enhanced lung gene expression after aerosol delivery of concentrated pDNA/PEI complexes. Mol Ther 2008;16:1283-90
   PubMed Web of Science ®Google Scholar
• Davies LA, Hyde SC, Nunez-Alonso G, The use of CpG-free plasmids to mediate persistent gene expression following repeated aerosol delivery of pDNA/PEI complexes. Biomaterials 2012;33:5618-27
   PubMed Web of Science ®Google Scholar
• Pfeifer C, Hasenpusch G, Uezguen S, Dry powder aerosols of polyethylenimine (PEI)-based gene vectors mediate efficient gene delivery to the lung. J Control Release 2011;154:69-76
   PubMed Web of Science ®Google Scholar
• Gazdhar A, Fachinger P, van LC, Gene transfer of hepatocyte growth factor by electroporation reduces bleomycin-induced lung fibrosis. Am J Physiol Lung Cell Mol Physiol 2007;292:L529-36
   PubMed Web of Science ®Google Scholar
• Mutlu GM, Hado-Aranda D, Norton JE, Electroporation-mediated gene transfer of the Na+,K+ -ATPase rescues endotoxin-induced lung injury. Am J Respir Crit Care Med 2007;176:582-90
   PubMed Web of Science ®Google Scholar
• Pringle IA, McLachlan G, Collie DD, Electroporation enhances reporter gene expression following delivery of naked plasmid DNA to the lung. J Gene Med 2007;9:369-80
   PubMed Web of Science ®Google Scholar
• Kaufman CD, Geiger RC, Dean DA. Electroporation- and mechanical ventilation-mediated gene transfer to the lung. Gene Ther 2010;17:1098-104
   PubMed Web of Science ®Google Scholar
• Xenariou S, Griesenbach U, Ferrari S, Using magnetic forces to enhance non-viral gene transfer to airway epithelium in vivo. Gene Ther 2006;13:1545-52
   PubMed Web of Science ®Google Scholar
• Xenariou S, Griesenbach U, Liang HD, Use of ultrasound to enhance nonviral lung gene transfer in vivo. Gene Ther 2007;14:768-74
   PubMed Web of Science ®Google Scholar
• Griesenbach U, Meng C, Farley R, The use of carboxymethylcellulose gel to increase non-viral gene transfer in mouse airways. Biomaterials 2010;31:2665-72
   PubMed Web of Science ®Google Scholar
• Griesenbach U, Meng C, Farley R, The role of doxorubicin in non-viral gene transfer in the lung. Biomaterials 2009;30:1971-7
   PubMed Web of Science ®Google Scholar
• Hyde SC, Pringle IA, Abdullah S, CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression. Nat Biotechnol 2008;26:549-51
   PubMed Web of Science ®Google Scholar
• Alton EW, Stern M, Farley R, Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial. Lancet 1999;353:947-54
   PubMed Web of Science ®Google Scholar
• Pringle IA, Raman S, Sharp WW, Detection of plasmid DNA vectors following gene transfer to the murine airways. Gene Ther 2005;12:1206-14
   PubMed Web of Science ®Google Scholar
• Stein S, Ott MG, Schultze-Strasser S, Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease. Nat Med 2010;16:198-204
   PubMed Web of Science ®Google Scholar
• Qin L, Ding Y, Pahud DR, Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression. Hum Gene Ther 1997;8:2019-29
   PubMed Web of Science ®Google Scholar
• Gill DR, Smyth SE, Goddard CA, Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1alpha promoter. Gene Ther 2001;8:1539-46
   PubMed Web of Science ®Google Scholar
• Yew NS, Przybylska M, Ziegler RJ, High and sustained transgene expression in vivo from plasmid vectors containing a hybrid ubiquitin promoter. Mol Ther 2001;4:75-82
   PubMed Web of Science ®Google Scholar
• Degiulio JV, Kaufman CD, Dean DA. The SP-C promoter facilitates alveolar type II epithelial cell-specific plasmid nuclear import and gene expression. Gene Ther 2010;17:541-9
   PubMed Web of Science ®Google Scholar
• Bazzani RP, Cai Y, Hebel HL, The significance of plasmid DNA preparations contaminated with bacterial genomic DNA on inflammatory responses following delivery of lipoplexes to the murine lung. Biomaterials 2011;32:9854-65
   PubMed Web of Science ®Google Scholar
• Munkonge FM, Amin V, Hyde SC, Identification and functional characterization of cytoplasmic determinants of plasmid DNA nuclear import. J Biol Chem 2009;284:26978-87
   PubMed Web of Science ®Google Scholar
• Chen ZY, He CY, Ehrhardt A, Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in vivo. Mol Ther 2003;8:495-500
   PubMed Web of Science ®Google Scholar
• Sinn PL, Shah AJ, Donovan MD, Viscoelastic gel formulations enhance airway epithelial gene transfer with viral vectors. Am J Respir Cell Mol Biol 2005;32:404-10
   PubMed Web of Science ®Google Scholar
• Chirmule N, Propert K, Magosin S, Immune responses to adenovirus and adeno-associated virus in humans. Gene Ther 1999;6:1574-83
   PubMed Web of Science ®Google Scholar
• Mudhakir D, Harashima H. Learning from the viral journey: how to enter cells and how to overcome intracellular barriers to reach the nucleus. AAPS J 2009;11:65-77
   PubMed Web of Science ®Google Scholar
• Lam AP, Dean DA. Progress and prospects: nuclear import of nonviral vectors. Gene Ther 2010;17:439-47
   PubMed Web of Science ®Google Scholar
• Ding W, Zhang L, Yan Z, Intracellular trafficking of adeno-associated viral vectors. Gene Ther 2005;12:873-80
   PubMed Web of Science ®Google Scholar
• Lee K, Ambrose Z, Martin TD, Flexible use of nuclear import pathways by HIV-1. Cell Host Microbe 2010;7:221-33
   PubMed Web of Science ®Google Scholar
• Matthay MA, Zemans RL. The acute respiratory distress syndrome: pathogenesis and treatment. Annu Rev Pathol 2011;6:147-63
   PubMed Web of Science ®Google Scholar
• Rubenfeld GD, Caldwell E, Peabody E, Incidence and outcomes of acute lung injury. N Engl J Med 2005;353:1685-93
   PubMed Web of Science ®Google Scholar
• Devaney J, Contreras M, Laffey JG. Clinical review: gene-based therapies for ALI/ARDS: where are we now? Crit Care 2011;15:224
   PubMed Web of Science ®Google Scholar
• Machado-Aranda DA, Suresh MV, Yu B, Electroporation-mediated in vivo gene delivery of the Na+/K+-ATPase pump reduced lung injury in a mouse model of lung contusion. J Trauma Acute Care Surg 2012;72:32-9
   Google Scholar
• Kabay B, Kocaefe C, Baykal A, Interleukin-10 gene transfer: prevention of multiple organ injury in a murine cecal ligation and puncture model of sepsis. World J Surg 2007;31:105-15
   PubMed Web of Science ®Google Scholar
• Ulrich K, Stern M, Goddard ME, Keratinocyte growth factor therapy in murine oleic acid-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol 2005;288:L1179-92
   PubMed Web of Science ®Google Scholar
• Huang YQ, Sauthoff H, Herscovici P, Angiopoietin-1 increases survival and reduces the development of lung edema induced by endotoxin administration in a murine model of acute lung injury. Crit Care Med 2008;36:262-7
   PubMed Web of Science ®Google Scholar
• Mei SH, McCarter SD, Deng Y, Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1. PLoS Med 2007;4:e269
   PubMed Web of Science ®Google Scholar
• Manning E, Pham S, Li S, Interleukin-10 delivery via mesenchymal stem cells: a novel gene therapy approach to prevent lung ischemia-reperfusion injury. Hum Gene Ther 2010;21:713-27
   PubMed Web of Science ®Google Scholar
• Aguilar S, Scotton CJ, McNulty K, Bone marrow stem cells expressing keratinocyte growth factor via an inducible lentivirus protects against bleomycin-induced pulmonary fibrosis. PLoS One 2009;4:e8013
   PubMed Web of Science ®Google Scholar
• Silverman EK, Sandhaus RA. Clinical practice. Alpha1-antitrypsin deficiency. N Engl J Med 2009;360:2749-57
   PubMed Web of Science ®Google Scholar
• Brigham KL, Lane KB, Meyrick B, Transfection of nasal mucosa with a normal alpha1-antitrypsin gene in alpha1-antitrypsin-deficient subjects: comparison with protein therapy. Hum Gene Ther 2000;11:1023-32
   PubMed Web of Science ®Google Scholar
• Brantly ML, Spencer LT, Humphries M, Phase I trial of intramuscular injection of a recombinant adeno-associated virus serotype 2 alphal-antitrypsin (AAT) vector in AAT-deficient adults. Hum Gene Ther 2006;17:1177-86
   PubMed Web of Science ®Google Scholar
• Brantly ML, Chulay JD, Wang L, Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy. Proc Natl Acad Sci USA 2009;106:16363-8
   PubMed Web of Science ®Google Scholar
• Flotte TR, Trapnell BC, Humphries M, Phase 2 clinical trial of a recombinant adeno-associated viral vector expressing alpha1-antitrypsin: interim results. Hum Gene Ther 2011;22:1239-47
   PubMed Web of Science ®Google Scholar
• Hubbard RC, Fells G, Gadek J, Neutrophil accumulation in the lung in alpha 1-antitrypsin deficiency. Spontaneous release of leukotriene B4 by alveolar macrophages. J Clin Invest 1991;88:891-7
   PubMed Web of Science ®Google Scholar
• Halbert CL, Madtes DK, Vaughan AE, Expression of human alpha1-antitrypsin in mice and dogs following AAV6 vector-mediated gene transfer to the lungs. Mol Ther 2010;18:1165-72
   PubMed Web of Science ®Google Scholar
• Griesenbach U, Vicente CC, Roberts MJ, Secreted Gaussia luciferase as a sensitive reporter gene for in vivo and ex vivo studies of airway gene transfer. Biomaterials 2011;32:2614-24
   PubMed Web of Science ®Google Scholar
• Maes T, Tournoy KG, Joos GF. Gene therapy for allergic airway diseases. Curr Allergy Asthma Rep 2011;11:163-72
   PubMed Web of Science ®Google Scholar
• Gauvreau GM, Boulet LP, Cockcroft DW, Antisense therapy against CCR3 and the common beta chain attenuates allergen-induced eosinophilic responses. Am J Respir Crit Care Med 2008;177:952-8
   PubMed Web of Science ®Google Scholar
• Gauvreau GM, Pageau R, Seguin R, Dose-response effects of TPI ASM8 in asthmatics after allergen. Allergy 2011;66:1242-8
   PubMed Web of Science ®Google Scholar
• Imaoka H, Campbell H, Babirad I, TPI ASM8 reduces eosinophil progenitors in sputum after allergen challenge. Clin Exp Allergy 2011;41:1740-6
   PubMed Web of Science ®Google Scholar
• Webb S. Attacks on asthma. Nat Biotechnol 2011;29:860-3
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Frontrunners in novel pharmacotherapy of COPD. Curr Opin Pharmacol 2008;8:300-7
   PubMed Web of Science ®Google Scholar
• Al-Jamal R, Wallace WA, Harrison DJ. Gene therapy for chronic obstructive pulmonary disease: twilight or triumph? Expert Opin Biol Ther 2005;5:333-46
   PubMed Web of Science ®Google Scholar
• Riordan JR, Rommens JM, Kerem B, Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989;245:1066-73
   PubMed Web of Science ®Google Scholar
• Quinton PM. Role of epithelial HCO3 transport in mucin secretion: lessons from cystic fibrosis. Am J Physiol Cell Physiol 2010;299:C1222-33
   PubMed Web of Science ®Google Scholar
• Welsh M, Ramsey BW, Accurso F, Cystic fibrosis. In: Scriver AB, Sly WS, Valle D. The molecular and metabolic basis of inherited disease. McGraw-Hill; New York: 2001. p. 5121-88
   Google Scholar
• Clunes MT, Boucher RC. Cystic fibrosis: the mechanisms of pathogenesis of an inherited lung disorder. Drug Discov Today Dis Mech 2007;4:63-72
   PubMedGoogle Scholar
• Alton EW, Middleton PG, Caplen NJ, Non-invasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice. Nat Genet 1993;5:135-42
   PubMed Web of Science ®Google Scholar
• Drumm ML, Pope HA, Cliff WH, Correction of the cystic fibrosis defect in vitro by retrovirus-mediated gene transfer. Cell 1990;62:1227-33
   PubMed Web of Science ®Google Scholar
• Chu CS, Trapnell BC, Curristin S, Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA. Nat Genet 1993;3:151-6
   PubMed Web of Science ®Google Scholar
• Johnson LG, Olsen JC, Sarkadi B, Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis. Nat Genet 1992;2:21-5
   PubMed Web of Science ®Google Scholar
• Farmen SL, Karp PH, Ng P, Gene transfer of CFTR to airway epithelia: low levels of expression are sufficient to correct Cl- transport and overexpression can generate basolateral CFTR. Am J Physiol Lung Cell Mol Physiol 2005;289:L1123-30
   PubMed Web of Science ®Google Scholar
• Johnson LG, Boyles SE, Wilson J, Normalization of raised sodium absorption and raised calcium-mediated chloride secretion by adenovirus-mediated expression of cystic fibrosis transmembrane conductance regulator in primary human cystic fibrosis airway epithelial cells. J Clin Invest 1995;95:1377-82
   PubMed Web of Science ®Google Scholar
• Harvey BG, Leopold PL, Hackett NR, Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of a recombinant adenovirus. J Clin Invest 1999;104:1245-55
   PubMed Web of Science ®Google Scholar
• Devincenzo JP. The promise, pitfalls and progress of RNA-interference-based antiviral therapy for respiratory viruses. Antivir Ther 2012;17:213-25
   PubMed Web of Science ®Google Scholar
• Alvarez R, Elbashir S, Borland T, RNA interference-mediated silencing of the respiratory syncytial virus nucleocapsid defines a potent antiviral strategy. Antimicrob Agents Chemother 2009;53:3952-62
   PubMed Web of Science ®Google Scholar
• Devincenzo J, Cehelsky JE, Alvarez R, Evaluation of the safety, tolerability and pharmacokinetics of ALN-RSV01, a novel RNAi antiviral therapeutic directed against respiratory syncytial virus (RSV). Antiviral Res 2008;77:225-31
   PubMed Web of Science ®Google Scholar
• Devincenzo J, Lambkin-Williams R, Wilkinson T, A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus. Proc Natl Acad Sci USA 2010;107:8800-5
   PubMed Web of Science ®Google Scholar
• Zamora MR, Budev M, Rolfe M, RNA interference therapy in lung transplant patients infected with respiratory syncytial virus. Am J Respir Crit Care Med 2011;183:531-8
   PubMed Web of Science ®Google Scholar
• Oishi H, Okada Y, Kikuchi T, Transbronchial human interleukin-10 gene transfer reduces acute inflammation associated with allograft rejection and intragraft interleukin-2 and tumor necrosis factor-alpha gene expression in a rat model of lung transplantation. J Heart Lung Transplant 2010;29:360-7
   PubMed Web of Science ®Google Scholar
• Hirayama S, Sato M, Liu M, Local long-term expression of lentivirally delivered IL-10 in the lung attenuates obliteration of intrapulmonary allograft airways. Hum Gene Ther 2011;22:1453-60
   PubMed Web of Science ®Google Scholar
• Jiang X, Khan MA, Tian W, Adenovirus-mediated HIF-1alpha gene transfer promotes repair of mouse airway allograft microvasculature and attenuates chronic rejection. J Clin Invest 2011;121:2336-49
   PubMed Web of Science ®Google Scholar
• Cypel M, Keshavjee S. Extracorporeal lung perfusion. Curr Opin Organ Transplant 2011;16:469-75
   PubMed Web of Science ®Google Scholar
• Yeung JC, Wagnetz D, Cypel M, Ex vivo adenoviral vector gene delivery results in decreased vector-associated inflammation pre- and post-lung transplantation in the pig. Mol Ther 2012;20:1204-11
   PubMed Web of Science ®Google Scholar
• Cypel M, Liu M, Rubacha M, Functional repair of human donor lungs by IL-10 gene therapy. Sci Transl Med 2009;1:4ra9
   PubMedGoogle Scholar
• Wert SE, Whitsett JA, Nogee LM. Genetic disorders of surfactant dysfunction. Pediatr Dev Pathol 2009;12:253-74
   PubMed Web of Science ®Google Scholar
• Yei S, Bachurski CJ, Weaver TE, Adenoviral-mediated gene transfer of human surfactant protein B to respiratory epithelial cells. Am J Respir Cell Mol Biol 1994;11:329-36
   PubMed Web of Science ®Google Scholar
• Kormann MS, Hasenpusch G, Aneja MK, Expression of therapeutic proteins after delivery of chemically modified mRNA in mice. Nat Biotechnol 2011;29:154-7
   PubMed Web of Science ®Google Scholar
• Chhin B, Negre D, Merrot O, Ciliary beating recovery in deficient human airway epithelial cells after lentivirus ex vivo gene therapy. PLoS Genet 2009;5:e1000422
   PubMedGoogle Scholar
• Stillwell PC, Wartchow EP, Sagel SD. Primary ciliary dyskinesia in children: a review for pediatricians, allergists, and pediatric pulmonologists. Pediatr Allergy Immunol Pulmonol 2011;24:191-6
   Web of Science ®Google Scholar
• The authors are strategy members of the UK Cystic Fibrosis Gene Therapy Consortium. Available from: http://www.cfgenetherapy.org.uk
   Google Scholar